When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ORPH - Orphazyme shares spike 95% in afternoon trading on eve of FDA PDUFA decision
Orphazyme A/S
CalypsoArt/iStock via Getty Images Shares of Orphazyme (ORPH) have suddenly shot up 95% in afternoon trading on the eve of an expected FDA decision on its application for Arimoclomol for the treatment of Niemann-Pick Disease Type C ("NPC"). Trading in the stock was already briefly halted three times this morning for 5 minutes each instance. Orphazyme is also partnered with CytRx (CYTR), which is up 9.5%.